Clinical Trial

Evaluating the Pharmacokinetics and Safety of Miricorilant

Name: Evaluating the Pharmacokinetics and Safety of Miricorilant — clinical trial record (NCT07553663)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of Miricorilant in Adult Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-27

Trial Details

NCT Number	NCT07553663
Lead Sponsor	Corcept Therapeutics
Conditions	Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-alcoholic Fatty Liver Disease (NAFLD)
Enrollment	15 participants
Start Date	2026-04-30
Primary Completion	2026-10-30 (estimated)
Study Completion	2026-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-26